Sort   by:  
 Page size 
TranscriptomicsATFS-1 mediates a protective transcription program during mitochondrial stress
ATFS-1 has been shown to regulate transcription of mitochondrial chaperone genes such as mtHsp70/hsp-6 and hsp-60 in response to mitocondrial stress. To identify the entire ATFS-1-mediated response, we compared the transcript profiles from wild-type and atfs-1(tm4525) worms raised in the absence and...
ORGANISM(S): Caenorhabditis elegans 
2012-07-11 | E-GEOD-38196 | biostudies-arrayexpress
MetabolomicsGNPS - Microbial and host compensation in a model of leucine breakdown deficiency
Representative MS/MS data for WT and mccc-1 mutant C. elegans reared on Comamonas aquatica. Data in both positive and negative ionization mode, as indicated in the files names. The worm bodies (endo-metabolome) and conditioned media (exo-metabolome) were harvested, extracted, and analyzed separately...
ORGANISM(S): Caenorhabditis Elegans (ncbitaxon:6239) 
2024-01-10 | MSV000093813 | GNPS
UnknownFrailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.
Not available
S-EPMC11390031 | biostudies-literature
UnknownLong-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.
Not available
S-EPMC7616743 | biostudies-literature
UnknownEffects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial.
Not available
S-EPMC7615591 | biostudies-literature
UnknownImpact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial.
Not available
S-EPMC7618536 | biostudies-literature
UnknownEffects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial.
Not available
S-EPMC12274867 | biostudies-literature
UnknownEmpagliflozin in Patients with Chronic Kidney Disease.
Not available
S-EPMC7614055 | biostudies-literature
UnknownLong term health outcomes in people with diabetes 12 months after hospitalisation with COVID-19 in the UK: a prospective cohort study.
Not available
S-EPMC11743801 | biostudies-literature
UnknownClinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study.
Not available
S-EPMC9034855 | biostudies-literature
Sort   by:  
 Page size